The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice

Anita M Tuomainen1, Kati Hyvärinen, Pauliina I Ehlers

  • 1Institute of Dentistry, University of Helsinki, FI-00014 Helsinki, Finland.

Microbial Pathogenesis
|March 23, 2011
PubMed
Abstract

Insights

Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) infections disrupt cholesterol balance and endothelial function, contributing to cardiovascular disease risk. These pathogens promote inflammation and alter macrophage activity, impacting vascular health.

Area of Science:

  • Cardiovascular Research
  • Infectious Diseases
  • Molecular Biology

Background:

  • Certain pathogens, including Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn), are linked to increased cardiovascular disease (CVD) risk.
  • These infections are known to induce systemic inflammation, a key factor in atherosclerosis development.

Purpose of the Study:

  • To investigate the impact of Aa and Cpn infections on cholesterol homeostasis within the vascular wall.
  • To determine how these pathogens affect endothelial function and contribute to CVD pathogenesis.

Main Methods:

  • Induction of Aa and Cpn infections in apoE-deficient mice.
  • Assessment of cholesterol efflux from macrophages and serum cholesterol efflux capacity.
  • Evaluation of endothelial function using rat mesenteric arteries and conditioned macrophage media.

Main Results:

  • Infections elevated inflammatory markers (SAA, TNF-α) and altered macrophage cholesterol metabolism (increased uptake, reduced efflux).
  • Reduced serum cholesterol efflux capacity was observed in Cpn-infected mice.
  • Endothelial dysfunction and increased adhesion molecule expression (ICAM, VCAM, E-selectin) were noted, correlating with SAA levels.

Conclusions:

  • Aa and Cpn infections induce proatherogenic changes in the vascular wall.
  • These changes are mediated by alterations in macrophage cholesterol homeostasis and endothelial function.
  • Pathogen-induced inflammation plays a critical role in the development of cardiovascular complications.